Gil Rodriguera

Gil Rodriguera has extensive work experience in compliance and pharmaceutical companies. In 1997, they began their career at Pfizer, where they worked in engineering until 2000. From 2000 to 2011, they held various roles at Merck, including Global Compliance Manager and Consent Decree Management Group Leader. Following this, they worked at PDI, Inc. as the Director of Compliance Operations from 2011 to 2013. In 2014, they joined IQVIA as a Principal, where they stayed until 2019. Gil then worked at Amarin Corporation as the Director of Compliance from 2019 to 2021, before joining Agile Therapeutics as the Senior Director of Compliance until 2022. Currently, Rodriguera serves as the Vice President and Compliance Officer at Provention Bio, a Sanofi Company.

Gil Rodriguera has a Master of Business Administration (MBA) degree from Long Island University. Gil also holds a Bachelor of Engineering (B.E.) degree from Stevens Institute of Technology. In addition, Gil has obtained a Healthcare Compliance Certification from Seton Hall Law School. However, no specific information is available regarding the start and end years of their education or the field of study for their degrees.